Brace Pharma
Venture capitalAtlanta Β· Late Stage Β· 3 people tracked
Investment thesis
Brace Pharma Capital invests in innovative therapies targeting diseases characterized by a high degree of unmet medical need and insufficient existing treatment options. The firm seeks to back companies developing life-changing medicines and invites prospective candidate investment companies to reach out for consideration.
Source: firm website, verified Aug 3, 2026.
Team Β· 3 people
from the firm's websiteSalazar leads clinical and regulatory work at Brace Pharma Capital and is Chief Scientific Officer and board member at EMS S/A. He has over 25 years in drug discovery and development, contributing to 40+ IND filings and 9 NDAs, and is an adjunct associate professor at the University of Florida. He previously held a senior translational medicine role at Otsuka Pharmaceutical Development.
Smith is an executive assistant and office manager at Brace Pharma Capital with experience in business operations across the medical, travel, and banking industries. She holds a master's degree in business management from Salem International University.
Brady leads finance and investments at Brace Pharma Capital and serves as a director for portfolio companies including GeNO, Avidity Biosciences, and Tyrogenex. He has a background across equity research, asset management, private equity, and corporate banking, holds an MBA from Schulich School of Business, and is a CFA charterholder.
What they invest in
from 7 of 15 portfolio companiesBiotech Γ7Medical Devices Γ4Healthtech Γ3Deep Tech Γ1Digital Health Γ1FemTech Γ1
HQs:United StatesΓ4
Investments Β· 15 tracked
founders shown can be your intro pathAntiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry.
BiotechFemTechHealthtechMedical DevicesRedwood City, US
Gail Maderis(Director)Kristine Ball(Executive Officer, Director)Elaine Chien(Executive Officer)Sarah Walter(Executive Officer)Raju Gadiraju(Executive Officer)Steven James(Director)
Avidity Biosciences develops Antibody Oligonucleotide Conjugates (AOCs) that combine monoclonal antibody specificity with oligonucleotide precision for targeted delivery of RNA therapeutics to treat rare genetic muscle diseases.
BiotechDeep TechHealthtechMedical Devices
Former board-observer relationship noted for Todd Brady.
BiotechCambridge, US
Jean-Francois Formela(Director)Rick Lundberg(Executive Officer)Alan Crane(Director)David Madden(Director)Marian Nakada(Director)Brian Gallagher(Director)
BiotechDurham, US
JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)TODD MELBY(Executive Officer)BEN AUSPITZ(Director)
BoardROBERT ADELMAN(Director)
BiotechNew York, US
Brad Bolzon(Director)Jose Manuel Otero(Executive Officer)Robert Gould(Director)Jerel Davis(Director)Jane Henderson(Executive Officer)Michael Burgess(Executive Officer)
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings.
BiotechHealthtechMedical Devices
Zymeworks develops novel medicines for patients with difficult-to-treat diseases using proprietary platforms and in-house R&D capabilities.
BiotechDigital HealthMedical DevicesVancouver
HAIG FARRIS(Director)SHERMAINE TILLEY(Director)NOEL HALL(Director)KENNETH GALBRAITH(Director)inNICK BEDFORD(Director)GORDON NG(Executive Officer)
Frequently asked questions
- What stage does Brace Pharma invest at?
- Brace Pharma invests at the Late Stage stage.
- What sectors does Brace Pharma focus on?
- Brace Pharma focuses on Biotech, Medical Devices.
- Where is Brace Pharma located?
- Brace Pharma is headquartered in Atlanta, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Capricorn Partners is an independent manager of venture capital funds and Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.